Lund University-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Lund University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011926
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lund University (LNU) is an educational service provider that offers master and bachelor programmes. It offers education and research in the areas of engineering, economics and management, science, law, social sciences, medicine, humanities, theology, fine art, music and others. The university spans its expertise in cancer research, neuroscience and neurodegenerative diseases, diabetes, stem cell therapy, epidemiology, Middle Eastern studies, materials science, and nanotechnology among others. It works in collaboration with other universities through international networks, cooperation platforms for research and education. LNU is headquartered in Lund, Sweden.

Lund University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lund University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Lund University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Lund University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Lund University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Lund University, Medical Devices Deals, 2011 to YTD 2017 9
Lund University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Lund University, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
RhoVac Enters into Research Agreement with Lund University 11
Rocket Pharma Entered into Research and Development Agreement with Lund University 12
Licensing Agreements 13
Avrobio Enters into Licensing Agreement with Lund University 13
Equity Offering 14
Akuru Pharma Spin Out from Lund University 14
Lund University – Key Competitors 15
Lund University – Key Employees 16
Lund University – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 18
Recent Developments 19
Government and Public Interest 19
Nov 30, 2017: Prestigious ERC grants awarded to Lund researchers 19
Nov 28, 2017: Molecular profiling of melanoma tumours explains differences in survival after T cell therapy 21
Nov 06, 2017: Helmsley Charitable Trust Awards $52 Million to Support the Global Platform for the Prevention of Autoimmune Diabetes 23
Nov 02, 2017: New research shows where in the brain the earliest signs of Alzheimers occur 25
Oct 25, 2017: New method helps rule out heart valve infection 27
Oct 05, 2017: Discovery of a new fusion gene class may affect the development of cancer 28
Sep 27, 2017: Grants to 18 research projects that may lead to future scientific breakthroughs 29
Jan 30, 2017: Unique mapping of methylome in insulin-producing islets 33
Oct 29, 2016: Breakthrough in the production of dopamine neurons for Parkinson’s disease 34
Jun 30, 2016: Lund University: Antidiabetic effects discovered in the appetite hormone CART 35
May 10, 2016: New technique can provide better cell transplants against Parkinson’s disease 36
Apr 20, 2016: Lund University: Using targeted missiles against aggressive cancer cells 37
Apr 13, 2016: Cartilage protein may contribute to the development of breast cancer 38
Product News 39
May 29, 2017: New test method aims to predict allergenic potency of chemicals 39
Other Significant Developments 40
Feb 06, 2017: An Innovative Medicines Initiative Project for Precision Medicine in DKD 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Lund University, Pharmaceuticals & Healthcare, Key Facts 2
Lund University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Lund University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Lund University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Lund University, Deals By Therapy Area, 2011 to YTD 2017 8
Lund University, Medical Devices Deals, 2011 to YTD 2017 9
Lund University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
RhoVac Enters into Research Agreement with Lund University 11
Rocket Pharma Entered into Research and Development Agreement with Lund University 12
Avrobio Enters into Licensing Agreement with Lund University 13
Akuru Pharma Spin Out from Lund University 14
Lund University, Key Competitors 15
Lund University, Key Employees 16
Lund University, Other Locations 17
Lund University, Subsidiaries 17
Lund University, Joint Venture 18

★海外企業調査レポート[Lund University-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Chugai Pharmaceutical Co., Ltd.:企業の戦略・SWOT・財務分析
    Chugai Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Chugai Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Falck Renewables SpA (FKR)
    Falck Renewables SpA (FKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Altimmune UK Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Altimmune UK Ltd (Altimmune), formerly Vaxin UK Limited, a subsidiary of Altimmune Inc, is a clinical stage immunotherapeutic biotechnology company that develops synthetic vaccines for mutating viruses. The company designs and develops immunotherapeutic products tailored to address a wide ra …
  • Centrex Metals Ltd:企業の戦略・SWOT・財務分析
    Centrex Metals Ltd - Strategy, SWOT and Corporate Finance Report Summary Centrex Metals Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • PTT Exploration and Production Public Co Ltd (PTTEP):企業の財務・戦略的SWOT分析
    PTT Exploration and Production Public Co Ltd (PTTEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Toshiba America Medical Systems Inc:製品パイプライン分析
    Summary Toshiba America Medical Systems Inc (TAMS), a subsidiary of Toshiba Medical Systems Corp, is a medical device company which markets and distributes the diagnostic imaging systems. The company offers cardiovascular X-ray, computed tomography, angiography, magnetic resonance, ultrasound and x- …
  • Nationwide Children’s Hospital-製薬・医療分野:企業M&A・提携分析
    Summary Nationwide Children's Hospital (Nationwide Children's) is a provider of pediatric health care and research services. The hospital offers pediatric services in the areas of gastroenterology, hematology and nutrition, heart care, left lip and palate, oncology ad bone marrow transplantation. It …
  • Heska Corp (HSKA):企業の財務・戦略的SWOT分析
    Heska Corp (HSKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • The Hershey Co:企業のM&A・事業提携・投資動向
    The Hershey Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Hershey Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • DS Smith Plc:企業のM&A・事業提携・投資動向
    DS Smith Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DS Smith Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Multiplicom NV-医療機器分野:企業M&A・提携分析
    Summary Multiplicom NV (Multiplicom) is a molecular diagnostic company that develops, manufactures and markets genetic test kits. The company offers onco genetics, human genetics and prenatal genetics products. Its human genetics products are used for cancer genetics, genetic disorders and neurologi …
  • Hays plc:企業の戦略・SWOT・財務情報
    Hays plc - Strategy, SWOT and Corporate Finance Report Summary Hays plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Centice Corporation-医療機器分野:企業M&A・提携分析
    Summary Centice Corporation (Centice) is a medical and electronic equipment company which designs, develops and offers advance sensors for various applications. The company’s products include BTL-200N, MFL-300N, BTL-200P, MFL-300P, and MFL-3000. It also provides illicit substances, prescription drug …
  • BICE Vida Compania de Seguros S.A.:企業の戦略・SWOT・財務情報
    BICE Vida Compania de Seguros S.A. - Strategy, SWOT and Corporate Finance Report Summary BICE Vida Compania de Seguros S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • BioClinica Inc:企業の戦略的SWOT分析
    BioClinica Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Noranda Income Fund (NIF.UN):企業の財務・戦略的SWOT分析
    Noranda Income Fund (NIF.UN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Codiak BioSciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Codiak BioSciences Inc (Codiak BioSciences) is an exosome therapeutics company that focuses on the development of proprietary pipeline of targeted medicines for diseases with unmet medical needs. The company’s platform capitalizes on exosomes, which are nanometer-sized membrane sacs that del …
  • BP Plc (BP.)-石油・ガス分野:企業M&A・提携分析
    Summary BP p.l.c. (BP) is an integrated oil and gas company. It provides fuel, energy, lubricants and petrochemicals to its customers. Its upstream activities include oil and natural gas exploration, field development and production; and midstream operations include transportation, and marketing and …
  • Constellation Software Inc (CSU):企業の財務・戦略的SWOT分析
    Constellation Software Inc (CSU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • MSIG Insurance (Singapore) Pte. Ltd.:企業の戦略・SWOT・財務情報
    MSIG Insurance (Singapore) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary MSIG Insurance (Singapore) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆